🇺🇸 FDA
Patent

US 8242080

Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface

granted A61KA61K38/00

Quick answer

US patent 8242080 (Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface) held by The Regents of the University of California expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/00